296 related articles for article (PubMed ID: 28178951)
1. High-sensitive C-reactive protein and risk of incident type 2 diabetes: a case-control study nested within the Singapore Chinese Health Study.
Pan A; Wang Y; Yuan JM; Koh WP
BMC Endocr Disord; 2017 Feb; 17(1):8. PubMed ID: 28178951
[TBL] [Abstract][Full Text] [Related]
2. Plasma ferritin, C-reactive protein, and risk of incident type 2 diabetes in Singapore Chinese men and women.
Wang YL; Koh WP; Yuan JM; Pan A
Diabetes Res Clin Pract; 2017 Jun; 128():109-118. PubMed ID: 28448891
[TBL] [Abstract][Full Text] [Related]
3. Association between the ratio of triglyceride to high-density lipoprotein cholesterol and incident type 2 diabetes in Singapore Chinese men and women.
Wang YL; Koh WP; Talaei M; Yuan JM; Pan A
J Diabetes; 2017 Jul; 9(7):689-698. PubMed ID: 27573855
[TBL] [Abstract][Full Text] [Related]
4. Plasma metabolomics identified novel metabolites associated with risk of type 2 diabetes in two prospective cohorts of Chinese adults.
Qiu G; Zheng Y; Wang H; Sun J; Ma H; Xiao Y; Li Y; Yuan Y; Yang H; Li X; Min X; Zhang C; Xu C; Jiang Y; Zhang X; He M; Yang M; Hu Z; Tang H; Shen H; Hu FB; Pan A; Wu T
Int J Epidemiol; 2016 Oct; 45(5):1507-1516. PubMed ID: 27694567
[TBL] [Abstract][Full Text] [Related]
5. Urine phyto-oestrogen metabolites are not significantly associated with risk of type 2 diabetes: the Singapore Chinese health study.
Talaei M; Lee BL; Ong CN; van Dam RM; Yuan JM; Koh WP; Pan A
Br J Nutr; 2016 May; 115(9):1607-15. PubMed ID: 26949260
[TBL] [Abstract][Full Text] [Related]
6. Relationship between inflammatory markers and mild cognitive impairment in Chinese patients with type 2 diabetes: a case-control study.
Zheng M; Chang B; Tian L; Shan C; Chen H; Gao Y; Huang G; Zhang M
BMC Endocr Disord; 2019 Jul; 19(1):73. PubMed ID: 31296192
[TBL] [Abstract][Full Text] [Related]
7. Multiple Biomarkers Improved Prediction for the Risk of Type 2 Diabetes Mellitus in Singapore Chinese Men and Women.
Wang Y; Koh WP; Sim X; Yuan JM; Pan A
Diabetes Metab J; 2020 Apr; 44(2):295-306. PubMed ID: 31769241
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.
Pradhan AD; Manson JE; Rifai N; Buring JE; Ridker PM
JAMA; 2001 Jul; 286(3):327-34. PubMed ID: 11466099
[TBL] [Abstract][Full Text] [Related]
9. Baseline high-sensitivity C-reactive protein predicts the risk of incident ankylosing spondylitis: Results of a community-based prospective study.
Su J; Cui L; Yang W; Shi H; Jin C; Shu R; Li H; Zeng X; Wu S; Gao X
PLoS One; 2019; 14(2):e0211946. PubMed ID: 30768617
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998.
Thorand B; Löwel H; Schneider A; Kolb H; Meisinger C; Fröhlich M; Koenig W
Arch Intern Med; 2003 Jan; 163(1):93-9. PubMed ID: 12523922
[TBL] [Abstract][Full Text] [Related]
11. Association between high sensitivity C-Reactive protein and prevalence of asymptomatic carotid artery stenosis.
Huang X; Wang A; Liu X; Chen S; Zhu Y; Liu Y; Huang K; Wu J; Chen S; Wu S; Zhao X
Atherosclerosis; 2016 Mar; 246():44-9. PubMed ID: 26752692
[TBL] [Abstract][Full Text] [Related]
12. High-sensitivity C-reactive protein and risk of type 2 diabetes: A nationwide cohort study and updated meta-analysis.
Yang X; Tao S; Peng J; Zhao J; Li S; Wu N; Wen Y; Xue Q; Yang CX; Pan XF
Diabetes Metab Res Rev; 2021 Nov; 37(8):e3446. PubMed ID: 33686799
[TBL] [Abstract][Full Text] [Related]
13. ADMA is a correlate of insulin resistance in early-stage diabetes independent of hs-CRP and body adiposity.
Nakhjavani M; Karimi-Jafari H; Esteghamati A; Khalilzadeh O; Asgarani F; Ghadiri-Anari A
Ann Endocrinol (Paris); 2010 Sep; 71(4):303-8. PubMed ID: 20434720
[TBL] [Abstract][Full Text] [Related]
14. Positive association between high-sensitivity C-reactive protein and incidence of type 2 diabetes mellitus in Japanese workers: 6-year follow-up.
Wang C; Yatsuya H; Tamakoshi K; Uemura M; Li Y; Wada K; Yamashita K; Kawaguchi L; Toyoshima H; Aoyama A
Diabetes Metab Res Rev; 2013 Jul; 29(5):398-405. PubMed ID: 23463453
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein and the risk of incident colorectal cancer.
Erlinger TP; Platz EA; Rifai N; Helzlsouer KJ
JAMA; 2004 Feb; 291(5):585-90. PubMed ID: 14762037
[TBL] [Abstract][Full Text] [Related]
16. Decreased plasma neuregulin 4 concentration is associated with increased high-sensitivity C-reactive protein in newly diagnosed type 2 diabetes mellitus patients: a cross-sectional study.
Yan PJ; Xu Y; Wan Q; Feng J; Li H; Gao CL; Yang J; Zhong HH; Zhang ZH
Acta Diabetol; 2017 Dec; 54(12):1091-1099. PubMed ID: 28918492
[TBL] [Abstract][Full Text] [Related]
17. Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality.
Parrinello CM; Lutsey PL; Ballantyne CM; Folsom AR; Pankow JS; Selvin E
Am Heart J; 2015 Aug; 170(2):380-9. PubMed ID: 26299237
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein levels and risk of stroke and its subtype in Japanese: The Circulatory Risk in Communities Study (CIRCS).
Chei CL; Yamagishi K; Kitamura A; Kiyama M; Imano H; Ohira T; Cui R; Tanigawa T; Sankai T; Ishikawa Y; Sato S; Iso H
Atherosclerosis; 2011 Jul; 217(1):187-93. PubMed ID: 21444086
[TBL] [Abstract][Full Text] [Related]
19. New pathways of increased cardiovascular risk in depression: a pilot study on the association of high-sensitivity C-reactive protein with pro-atherosclerotic markers in patients with depression.
Zahn D; Petrak F; Uhl I; Juckel G; Neubauer H; Hägele AK; Wiltfang J; Herpertz S
J Affect Disord; 2013 Apr; 146(3):420-5. PubMed ID: 22999070
[TBL] [Abstract][Full Text] [Related]
20. The plasma leptin/adiponectin ratio predicts first cardiovascular event in men: a prospective nested case-control study.
Kappelle PJ; Dullaart RP; van Beek AP; Hillege HL; Wolffenbuttel BH
Eur J Intern Med; 2012 Dec; 23(8):755-9. PubMed ID: 22819464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
